Seattle, WA (PRWEB) June 18, 2013
Though health care jobs continued to be added in May -- 11,000, according to the U.S. Bureau of Labor Statistics -- the increase was far below the calendar year's average increase of 24,000 per month. Most new health care jobs were added in home health care and outpatient care, while the hospital sector saw a loss of 6,000 jobs. Overall, the U.S. unemployment rate stayed flat at 7.6 percent. Global outplacement consultancy firm Challenger, Gray & Christmas reported that a total of just over 36,000 job cuts were planned for April, more than 40 percent less than similar announcements made a year ago.
While some layoffs in pharmaceuticals have occurred in the U.S. in the past month, the biggest news seems to be coming from non-American locations. Pharmaxis Ltd, an Australian company who makes drugs to combat chronic illnesses, is cutting 30 percent of its workforce (reuters.com, 5/27/13), and the Australian branch of GlaxoSmithKline is closing a tablet-packaging facility that will see 120 jobs eliminated (theaustralian.com.au, 5/22/13). Meanwhile, in France, Sanofi is engaged in a cost-cutting measure, phasing out more than 100 jobs but not planning any active layoffs in the process (bloomberg.com, 5/17/13).
U.S. employees were not shielded from major layoff announcements in May, though. Indian pharmaceutical corporation Ranbaxy, who has come under fire in the past in the U.S. for manufacturing issues, is considering eliminating about a third of its global sales force jobs -- almost 5,000 positions, and, according to rediff.com (5/23/13), a majority of them will be in the U.S. Medtronics also made cuts in May, specifically in their spinal division; 230 people were affected (startribune.com, 5/2/13).
There was some good
Copyright©2012 Vocus, Inc.
All rights reserved